Efficacy of the In2Care ® auto-dissemination device for reducing dengue transmission: study protocol for a parallel, two-armed cluster randomised trial in the Philippines
DiscussionFor decades, it has been commonly accepted that an integrated approach to mosquito control is required. The World Health Organization (WHO) Global Strategic Framework for Integrated Vector Management recommends a range of interventions, in combination, to increase control impact to reduce transmission. This efficacy trial of the first commercial product using the AD approach will be informative in assessing the general utility of AD in reducing not only adult vector densities but, more importantly, reducing the incidence of dengue. The AD technique may complement source reduction and larviciding campaigns by more...
Source: Trials - May 13, 2019 Category: Research Source Type: clinical trials
Surveillance of Zika-related Microcephaly in Sub-Saharan Africa and Asia
Conditions: Microcephaly; Congenital Infection Intervention: Diagnostic Test: Differential diagnosis for infectious causes of microcephaly Sponsors: Institut Pasteur; Centre Pasteur du Cameroun; Guangzhou Women and Children's Medical Center; Institut Pasteur de Côte d'Ivoire; Institut Pasteur Ho Chi Minh City; Tu Du Hospital; Perinatal Society of Sri Lanka; University of Colombo; University of Lausanne; University of Lausanne Hospitals; The University of Hong Kong; Ministry of Health of Sri Lanka; Central Hospital Maternity; Ess...
Source: ClinicalTrials.gov - April 22, 2019 Category: Research Source Type: clinical trials
Surveillance of Zika-related Microcephaly in Sub-Saharan Africa and Asia
Conditions: Microcephaly; Congenital Infection Intervention: Diagnostic Test: Differential diagnosis for infectious causes of microcephaly Sponsors: Institut Pasteur; Centre Pasteur du Cameroun; Guangzhou Women and Children's Medical Center; Institut Pasteur de Côte d'Ivoire; Institut Pasteur Ho Chi Minh City; Tu Du Hospital; Perinatal Society of Sri Lanka; University of Colombo; University of Lausanne; University of Lausanne Hospitals; The University of Hong Kong; Ministry of Health of Sri Lanka; Central Hospital Maternity; Ess...
Source: ClinicalTrials.gov - April 22, 2019 Category: Research Source Type: clinical trials
Safety and Tolerability of an Antibody Against Zika Virus (Tyzivumab) in ZIKV Infected Patients
Condition: Treatment of Acute Zika Virus Infection Interventions: Biological: Tyzivumab; Other: Placebo Sponsors: Tychan Pte Ltd.; Singapore Clinical Research Institute; Duke-NUS Graduate Medical School Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 17, 2018 Category: Research Source Type: clinical trials
